Preterm Birth Control Market to 2025 - Global Analysis and Forecasts By Treatment Method (Devices and Pharmaceutical Treatment), and Geography
Publication Month: Sep 2018
Report Code: TIPMD00002026 No. of Pages: 115 Category: Medical Device Status: Published
The global preterm birth control market is expected to reach US$ 1,809.0 Mn in 2025 from US$ 1,190.5 in 2017. The market is estimated to grow with a CAGR of 4.9% from 2018-2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. The Asia Pacific per-term birth control market is expected to grow with CAGR of 5.1% to US$ 325.6 Mn in 2025 from US$ 222.4 Mn in 2017.
Lucrative Regional Markets
Get more information on this report :
Market Insights
Increasing Number of Preterm Births
There has been a gradual increase in the number of preterm births from last few years. As per the World Health Organization (WHO), premature birth is a leading cause of death among the child below 5 years of age. It may be due to early induction of labor or caesarean birth. Multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure are others common causes of preterm births. As per the Centers for Disease Control and Prevention (CDC), reduction in preterm birth was observed from 2007-2014. In 2015, low birth weight and preterm birth accounted for about 17% of infant deaths. However, the number increased during 2016, with racial and ethnic differences. In the US, 1 of every 10 infants born was a preterm birth.
Initiatives towards Prevention of Preterm Birth
A number of government and non-government organizations are engaged increasing awareness about preterm birth in various countries across the globe. Organizations such as CDC has implemented strategies to reduce preterm births. These strategies includes provision of healthcare services before and between pregnancies; determining population at the risk of preterm delivery and provide immediate treatment, discouraging deliveries before 39 weeks without a medical need; and preventing unintended pregnancies by waiting for at least 18 months between pregnancies.
Stringent Regulatory Framework
Regulatory authorities such as Food & Drug Administration (FDA), European Medicine Agency (EMA) and others has consistently shown a tough stance towards pharmaceutical can biotechnology manufacturers. The market players must comply with the requirement and guidelines of FDA and other regulatory authorities and should constantly keep a check over time to time changes made in these guidelines. The manufacturers of pharmaceutical drugs and medical devices must abide by these regulations pertaining to current good manufacturing practices (cGMP) as well as good laboratory practices (GLP) in order to assure proper design, monitoring, and control of manufacturing processes and facilities. Furthermore, any deviations from the registered protocols, demands and requirements of these guidance leads to termination of the clinical trials undertaken by the pharmaceutical companies.
Additionally, FDA also requires strong safety monitoring and a strict dispensing plan to be followed by the manufacturer. Non-compliance by the manufacturers affects the sales of the products in the market and may lead to the recalls for marketed products due to instances recorded for deficit of the promises in the function and performance of the product or therapeutic may tarnish the company’s reputation risking its future growth. In case of clinical trials for development of therapeutics for preterm birth control, the FDA and other regulatory bodies have strict regulations due to which it is difficult for the manufacturers to pool in pregnant patients generating lack of working models. This in turn results into rejection of trials and can thus act as hindrance to the market growth.
Product Insights
The pre-term birth control market by treatment method is segmented into pharmaceutical treatment and devices. The pharmaceutical treatment segment is poised to grow with a largest market share of 55.6% in 2017. The market for pharmaceutical treatment is anticipated to surge during the forecast period from 2017 to 2025, at a significant rate.
Pre-term birth control Market, by Treatment method
Get more information on this report :
Strategic Insights
Collaborations/ acquisitions were observed as the most adopted strategy in global pre-term birth control industry. Few of the product launches and agreements made by the players in the market are listed below;
2018: CooperSurgical had acquired the assets of The LifeGlobal Group and its affiliates. The LifeGlobal Group is a leading global provider of in-vitro fertilization devices.
PRE-TERM BIRTH CONTROL – MARKET SEGMENTATION
By Treatment method- Devices
- Cervical Cerclage
- Vaginal Pessaries
- Pharmaceutical treatment
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- U.K
- Asia Pacific
- Japan
- China
- India
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- South & Central America
- Argentina
- Brazil
- Cooper Surgical
- Medgyn Products
- Integra Life sciences Corporation
- Panpac Medical Corp.
- Dr. Arabin GMBH & Co. KG
- Amag Pharmaceuticals
- Ben Way Enterprises Sdn Bhd
- Personal Medical Corp.
- Bioteque America Inc.
- Bliss Gvs Pharma Ltd.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Global Preterm birth control Market – Key takeaways
3. Global preterm birth control Market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Global Preterm Birth Control Market – By Treatment Method
3.2.2 Global Preterm Birth Control Market – By Geography
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis
4. Global Preterm birth control market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Number of Preterm Births
4.1.2 Initiatives Towards Prevention of Preterm Birth
4.2 Key Market Restraints
4.2.1 Stringent Regulatory Framework
4.3 Key Market Opportunities
4.3.1 Growth of Pharmaceutical Industry
4.3.2 Increasing Healthcare Expenditure in Emerging Markets
4.4 Future Trends
4.4.1 Uses Nanotechnology to Prevent Preterm Birth
4.5 Impact analysis
5. PRETERM BIRTH CONTROL Market – Global Analysis
5.1 global PRETERM BIRTH CONTROL Market Revenue Forecasts and Analysis
5.2 global PRETERM BIRTH CONTROL Market, By Geography - Forecasts and Analysis
5.3 expert opinions
6. Preterm Birth Control market analysis– by Treatment method
6.1 overview
6.2 Devices MARKET
6.2.1 Overview
6.2.2 Global Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.2.3 Cervical Cerclage Devices Market
6.2.3.1 Overview
6.2.3.2 Global Cervical Cerclage Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.2.4 Vaginal Pessaries Market
6.2.4.1 Overview
6.2.4.2 Global Vaginal Pessaries Market Revenue and Forecasts to 2025 (US$ Mn)
6.3 Pharmaceutical Treatment MARKET
6.3.1 Overview
6.3.2 Global Pharmaceutical Treatment Market Revenue and Forecasts to 2025 (US$ Mn)
7. North America Preterm birth control Market Revenue and Forecasts to 2025
7.1 Overview
7.2 North America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.3 North America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
7.3.1 North America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.4 North America Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
7.5 US Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.5.1 US Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.5.2 US Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method(US$ Mn)
7.5.2.1 US Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.6 Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.6.1 Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.6.2 Canada Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
7.6.2.1 Canada Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
7.7 Mexico Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
7.7.1 Mexico Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
7.7.2 Mexico Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
7.7.2.1 Mexico Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8. Europe preterm birth control Market Revenue and Forecasts to 2025
8.1 Overview
8.2 Europe Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.3 Europe Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
8.3.1 Europe Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4 Europe Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
8.5 Germany Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.5.1 Germany Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.5.2 Germany Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.5.2.1 Germany Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6 UK Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.1 UK Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.2 UK Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.6.2.1 UK Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.7 France Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.1 France Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.2 France Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
8.7.2.1 France Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9. Asia pacific Preterm birth control Market Revenue and Forecasts to 2025
9.1 Overview
9.2 asia pacific Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Asia Pacific Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.3.1 Asia Pacific Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.4 Asia Pacific Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
9.5 China Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.5.1 China Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.5.2 China Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.5.2.1 China Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.6 Japan Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.6.1 Japan Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
9.6.2 Japan Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.6.2.1 Japan Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.7 India Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 India Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 India Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
9.7.2.1 India Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10. Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025
10.1 Overview
10.2 Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.3 Middle East and Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.3.1 Middle East and Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.4 Middle East and Africa Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
10.5 UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.6 UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.6.1 UAE Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.6.1.1 UAE Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.7 Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.8 Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.8.1 Saudi Arabia Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.8.1.1 Saudi Arabia Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
10.9 South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.10 South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
10.10.1 South Africa Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
10.10.1.1 South Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11. south and central america preterm birth control Market Revenue and Forecasts to 2025
11.1 Overview
11.2 South and Central America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
11.3 South and Central America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
11.3.1 South and Central America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
11.4 South and Central America Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
11.5 Brazil Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.1 Brazil Preterm Birth Control Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.2 Brazil Preterm Birth Control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
11.5.2.1 Brazil Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
12. PRETERM BIRTH CONTROL MARKET–KEY COMPANY PROFILES
12.1 CooperSurgical, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 Swot Analysis
12.1.6 Key Developments
12.2 MEDGYN PRODUCTS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Integra LifeSciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Panpac Medical Corp.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Dr. Arabin GmbH & Co. KG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Information
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 AMAG Pharmaceuticals
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 Swot Analysis
12.6.6 Key Developments
12.7 BEN WAY ENTERPRISES SDN BHD
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 Personal Medical Corp.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 Swot Analysis
12.8.6 Key Developments
12.9 Bioteque America, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 Swot Analysis
12.9.6 Key Developments
12.10 Bliss GVS Pharma Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
TABLE 1. preterm births by countires, 2015
TABLE 2. North America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Type (US$ Mn)
TABLE 3. North America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 4. Investments for preterm birth control studies
TABLE 5. US Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 6. US Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 7. Canada Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 8. Canada Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 9. Mexico Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 10. Mexico Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 11. Europe Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
TABLE 12. Europe Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 13. Germany Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 14. Germany Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 15. UK Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 16. UK Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 17. France Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 18. France Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 19. Asia Pacific Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 20. Asia Pacific Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 21. China Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 22. China Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 23. Japan Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 24. Japan Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 25. India Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 26. India Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 27. Middle East and Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 28. Middle East and Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 29. Middle East and Africa Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
TABLE 30. UAE Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 31. UAE Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 32. Saudi Arabia Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 33. Saudi Arabia Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 34. South Africa Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 35. South Africa Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 36. South and Central America Preterm birth control Market Revenue And Forecasts to 2025, By Treatment method (US$ Mn)
TABLE 37. South and Central America Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 38. Brazil Preterm birth control Market Revenue And Forecasts to 2025, By Treatment Method (US$ Mn)
TABLE 39. Brazil Devices Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 40. Glossary of Terms, Preterm birth control market
LIST OF FIGURES
FIGURE 1. Asia Pacific Preterm birth control market, Revenue (US$ Mn), By Geography 2018 & 2025
FIGURE 2. Global Preterm birth control Market By product, Market Share (%), 2017
FIGURE 3. Preterm birth control Market Segmentation
FIGURE 4. Preterm birth control Segmentation, by region
FIGURE 5. North America PEST Analysis
FIGURE 6. Europe PEST Analysis
FIGURE 7. Asia pacific PEST Analysis
FIGURE 8. South and central america PEST Analysis
FIGURE 9. Preterm Birth Control market impact analysis of driver and restraints
FIGURE 10. global PRETERM BIRTH CONTROL Market – Revenue Forecasts and Analysis – 2016- 2025
FIGURE 11. global PRETERM BIRTH CONTROL Market – by geography Forecasts and Analysis – 2017- 2025
FIGURE 12. global Preterm Birth Control market breakdown, by treatment method 2017 & 2025 (%)
FIGURE 13. global Devices market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. global Cervical Cerclage Devices market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. global Vaginal Pessaries market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. global Pharmaceutical Treatment market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. North America preterm birth control Market Overview, by Country (2017)
FIGURE 18. North America Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. North America Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 20. US preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Canada Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. Mexico Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Europe preterm birth control Market Overview, by Country (2017)
FIGURE 24. Europe Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. Europe Preterm birth control Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 26. Germany Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. UK preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 28. France Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Asia Pacific preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 30. asia pacific Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Asia Pacific Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 32. China preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Japan Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 34. India Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 35. Middle East and Africa preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 36. Middle East and Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 37. UAE Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 38. Saudi Arabia Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 39. South Africa Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 40. South and Central America preterm birth control Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 41. South and Central America Preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 42. South and Central America Preterm birth control Market SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 43. Brazil preterm birth control Market Revenue and Forecasts to 2025 (US$ Mn)
The List of Companies
- CooperSurgical, Inc.
- MEDGYN PRODUCTS, INC.
- Integra LifeSciences Corporation
- Panpac Medical Corp.
- Personal Medical Corp
- Bioteque America, Inc.
- Bliss GVS Pharma Ltd.
- Dr. Arabin GmbH & Co. KG
- AMAG Pharmaceuticals
- BEN WAY ENTERPRISES SDN BHD
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the preterm birth control market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global preterm birth control market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.